Delivery Order SPE2DB24D8002-SPE2DB25FJMZV
Award Date
1/21/25
Potential Completion Date
1/22/25
Potential Value
$6.4K
Federal Agency
Defense Logistics Agency
Awardee
Dakota Drug, Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Dakota Drug, Inc., a self-certified small disadvantaged business, was issued by the Defense Logistics Agency (DLA) for the delivery of 4566854010 - LOSARTAN-HCTZ 100-25 MG TAB 90S. The contract has a ceiling value of $1,454.42 and a period of performance through January 8, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by Dakota Drug, Inc. with the DLA, valued at $999,999,999.00, which allows the company to provide a comprehensive...
This federal contract award to Dakota Drug, Inc., a self-certified small disadvantaged business, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,807.32 firm fixed-price delivery order is for the supply of Losartan-HCTZ 100-12.5 mg tablets. This order is part of a larger $999,999,999.00 indefinite delivery contract (SPE2DB24D8001) held by Dakota Drug, Inc. under the DLA Troop Support Medical's ECAT Generation V Program, which procures commercial medical equipment,...
This federal contract award, identified as SPE2DB24D8003|SPE2DB25FJTJJ, was issued by the Defense Logistics Agency (DLA) for the delivery of Losartan-HCTZ 100-25 mg tablets in 90-count packages. The $2,777.68 fixed-price delivery order was awarded to Dakota Drug, Inc., a self-certified small disadvantaged business, on November 26, 2024, with a completion date of November 27, 2024. Dakota Drug, Inc. is a key supplier to the DLA Troop Support Medical division, holding a significant $999,999,999.00...
This federal contract award, valued at $14,626.01, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is a Firm Fixed Price Delivery Order for the delivery of 90-count bottles of Losartan-HCTZ 100-12.5 mg tablets. Dakota Drug, Inc. is a key supplier to the DLA Troop Support Medical division, holding a significant single-award Indefinite Delivery Contract (IDC) valued at $999,999,999.00 for the provision of a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $18,462.43 firm fixed-price contract is for the delivery of 4566847986 LOSARTAN-HCTZ 100-25 MG TAB 90S to support U.S. Armed Forces medical operations. The contract has an ultimate completion date of January 7, 2025 and is not a set-aside. Dakota Drug, Inc. is also the prime contractor on a larger $999,999,999.00 Indefinite Delivery Contract...
This federal contract award to Dakota Drug, Inc., a self-certified small disadvantaged business, was issued by the Defense Logistics Agency (DLA) Troop Support Medical division. The contract, valued at $6,169.79, is a Firm Fixed Price Delivery Order for the provision of DIOVAN HCT 160-25 MG TABLET 90S, a pharmaceutical product. The award is part of a larger Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001, valued at $999,999,999.00. This contract, which is part of the...
This federal contract award, identified as SPE2DX15D8001|SPE2DX24FBQKB, was issued by the Defense Logistics Agency (DLA) to the prime contractor Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $2,886.34, is for the delivery of Diovan HCT 160-25 mg tablets to support the DLA's Troop Support Medical division. This is a firm-fixed-price delivery order contract with a completion date of February 7, 2024. Dakota Drug, Inc. has also been awarded a larger...
This federal contract award, SPE2DX15D8003|SPE2DX24F7B8G, was issued by the Defense Logistics Agency (DLA) to the prime contractor, Dakota Drug, Inc., a self-certified small disadvantaged business. The $3,934.98 firm fixed-price delivery order is for the provision of MICARDIS 20 MG TABLET UD 30S, a pharmaceutical product. Dakota Drug, Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001, valued at $999,999,999.00, which is part of the...
This federal contract award, identified as SPE2DX15D8003|SPE2DX24F7C2J, was made by the Defense Logistics Agency (DLA) Troop Support Medical division to Dakota Drug, Inc., a self-certified small disadvantaged business. The $2,268.40 firm fixed-price delivery order is for the supply of MICARDIS 40 MG TABLET UD 30S, a pharmaceutical product, with a period of performance extending until January 4, 2024. Dakota Drug, Inc. is a key supplier for the DLA, holding a significant single-award Indefinite...
This federal contract award SPE2DX15D8002|SPE2DX24F2WS3, valued at $1,651.67, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of DAPAGLIFLOZIN 5 MG TABLET 30S, a pharmaceutical product, to support the DLA Troop Support Medical division. This award is not associated with a set-aside program. Additionally, Dakota Drug, Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA,...